S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NASDAQ:ACOR

Acorda Therapeutics News Headlines

$7.22
-0.82 (-10.20 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.06
Now: $7.22
$8.25
50-Day Range
$0.69
MA: $4.43
$7.97
52-Week Range
$2.53
Now: $7.22
$15.30
Volume898,307 shs
Average Volume3.75 million shs
Market Capitalization$57.72 million
P/E Ratio1.31
Dividend YieldN/A
Beta0.75

Headlines

Acorda Therapeutics (NASDAQ ACOR) News Headlines Today

Source:
SourceHeadline
Acorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to BuyAcorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to Buy
marketbeat.com - January 18 at 4:41 PM
Acorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to "Buy"Acorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to "Buy"
marketbeat.com - December 21 at 4:18 PM
Dalfampridine Market 2021: Trends, Drivers, Strategies, Applications and Competitive Landscape 2026Dalfampridine Market 2021: Trends, Drivers, Strategies, Applications and Competitive Landscape 2026
marketwatch.com - January 20 at 7:26 PM
Acorda Stock at $35 a Share? This Analyst Thinks It’s PossibleAcorda Stock at $35 a Share? This Analyst Thinks It’s Possible
finance.yahoo.com - January 16 at 5:14 AM
Acorda Therapeutics (NASDAQ:ACOR) Stock Price Up 5.2%Acorda Therapeutics (NASDAQ:ACOR) Stock Price Up 5.2%
americanbankingnews.com - January 15 at 7:24 PM
Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At ...Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At ...
businesswire.com - January 15 at 7:06 AM
Acorda (ACOR) Soars on Sale of Manufacturing Unit for InbrijaAcorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija
finance.yahoo.com - January 14 at 5:32 PM
Stock Alert: Acorda Therapeutics Gains 50% On Plan To Sell INBRIJAStock Alert: Acorda Therapeutics Gains 50% On Plan To Sell INBRIJA
nasdaq.com - January 13 at 2:33 PM
Acorda Therapeutics (NASDAQ:ACOR) Price Target Raised to $35.00 at CowenAcorda Therapeutics (NASDAQ:ACOR) Price Target Raised to $35.00 at Cowen
americanbankingnews.com - January 13 at 2:24 PM
Acorda Therapeutics (NASDAQ:ACOR) Shares Gap Up to $4.24Acorda Therapeutics (NASDAQ:ACOR) Shares Gap Up to $4.24
americanbankingnews.com - January 13 at 11:54 AM
Acorda Therapeutics, NuCana leads healthcare gainers; Zomedica, Forward Pharma  among major losersAcorda Therapeutics, NuCana leads healthcare gainers; Zomedica, Forward Pharma among major losers
seekingalpha.com - January 13 at 11:03 AM
Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into "At The Market" Offering AgreementAcorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into "At The Market" Offering Agreement
finance.yahoo.com - January 13 at 8:50 AM
Acorda Therapeutics to Present at 39th Annual J.P. Morgan Health Care ConferenceAcorda Therapeutics to Present at 39th Annual J.P. Morgan Health Care Conference
finance.yahoo.com - January 12 at 4:43 PM
Acorda Therapeutics to Present at H.C. Wainwright BIOCONNECT Virtual ConferenceAcorda Therapeutics to Present at H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 11 at 7:34 PM
Acorda Therapeutics (NASDAQ:ACOR) Trading Up 6.3%Acorda Therapeutics (NASDAQ:ACOR) Trading Up 6.3%
americanbankingnews.com - January 5 at 8:56 PM
Comparing Acorda Therapeutics (NASDAQ:ACOR) and Editas Medicine (NASDAQ:EDIT)Comparing Acorda Therapeutics (NASDAQ:ACOR) and Editas Medicine (NASDAQ:EDIT)
americanbankingnews.com - January 5 at 7:16 AM
Bionano Genomics, Ocugen leads healthcare gainers; Calithera Biosciences, Acorda Therapeutics among major losersBionano Genomics, Ocugen leads healthcare gainers; Calithera Biosciences, Acorda Therapeutics among major losers
seekingalpha.com - January 4 at 12:02 PM
Acorda Therapeutics Announces Completion of One-for-Six Reverse Stock SplitAcorda Therapeutics Announces Completion of One-for-Six Reverse Stock Split
finance.yahoo.com - December 31 at 7:47 PM
Acorda Therapeutics completes 1-for-6 reverse stock splitAcorda Therapeutics completes 1-for-6 reverse stock split
seekingalpha.com - December 31 at 6:04 PM
Spinal Cord Trauma Treatment Market Size 2021 by Share, Market Dynamics, Company Overview and Investment Analysis Business Overview to 2024Spinal Cord Trauma Treatment Market Size 2021 by Share, Market Dynamics, Company Overview and Investment Analysis Business Overview to 2024
marketwatch.com - December 23 at 1:10 PM
Is ACOR A Good Stock To Buy Now?Is ACOR A Good Stock To Buy Now?
finance.yahoo.com - December 8 at 2:26 AM
Spinal Cord Trauma Treatment Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19Spinal Cord Trauma Treatment Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19
marketwatch.com - November 9 at 9:11 AM
Analysts Are More Bearish On Acorda Therapeutics, Inc. (NASDAQ:ACOR) Than They Used To BeAnalysts Are More Bearish On Acorda Therapeutics, Inc. (NASDAQ:ACOR) Than They Used To Be
nasdaq.com - November 8 at 8:41 AM
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Analysts Are Reducing Their Forecasts For Next YearAcorda Therapeutics, Inc. (NASDAQ:ACOR) Analysts Are Reducing Their Forecasts For Next Year
finance.yahoo.com - November 8 at 8:41 AM
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call TranscriptAcorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 10:51 PM
Acorda Therapeutics: Q3 Earnings InsightsAcorda Therapeutics: Q3 Earnings Insights
benzinga.com - November 3 at 5:50 PM
Acorda Therapeutics EPS beats by $0.10, beats on revenueAcorda Therapeutics EPS beats by $0.10, beats on revenue
seekingalpha.com - November 3 at 5:50 PM
Acorda Reports Third Quarter 2020 Financial ResultsAcorda Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 3 at 5:50 PM
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSureThe Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
finance.yahoo.com - November 3 at 12:49 PM
Preview: Acorda Therapeuticss EarningsPreview: Acorda Therapeutics's Earnings
finance.yahoo.com - November 2 at 6:03 PM
Acorda Third Quarter 2020 Update: Webcast/Conference Call Scheduled for November 3, 2020Acorda Third Quarter 2020 Update: Webcast/Conference Call Scheduled for November 3, 2020
finance.yahoo.com - October 27 at 8:05 AM
Acorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseAcorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 26 at 5:44 PM
Looking Into Acorda Therapeuticss Return On Capital EmployedLooking Into Acorda Therapeutics's Return On Capital Employed
benzinga.com - October 22 at 10:24 PM
Why Acordas Stock Is Trading Higher TodayWhy Acorda's Stock Is Trading Higher Today
benzinga.com - October 22 at 1:15 AM
Looking Into Acorda Therapeutics's Return On Capital EmployedLooking Into Acorda Therapeutics's Return On Capital Employed
finance.yahoo.com - October 20 at 5:37 PM
Why Acorda's Stock Is Trading Higher TodayWhy Acorda's Stock Is Trading Higher Today
finance.yahoo.com - October 20 at 5:37 PM
Acorda Therapeutics Inc. Regist (CDG.SG)Acorda Therapeutics Inc. Regist (CDG.SG)
au.finance.yahoo.com - October 10 at 12:00 AM
Are Options Traders Betting on a Big Move in Acorda Therapeutics (ACOR) Stock?Are Options Traders Betting on a Big Move in Acorda Therapeutics (ACOR) Stock?
nasdaq.com - September 29 at 1:19 PM
4 Top Penny Stocks Reaching New Highs Today; 1 Up 60%+ In September4 Top Penny Stocks Reaching New Highs Today; 1 Up 60%+ In September
marketwatch.com - September 26 at 2:38 AM
Diclofenac Patches Market Top Key Players, Share, Capacity, Entry Strategies, Production and Production Value and Forecast 2020 to 2026Diclofenac Patches Market Top Key Players, Share, Capacity, Entry Strategies, Production and Production Value and Forecast 2020 to 2026
marketwatch.com - September 8 at 12:31 PM
Post herpetic Neuralgia Treatment Market 2020 Top Manufacturers, Industry Share, Size, Trends, Growth Factor and Forecast 2025Post herpetic Neuralgia Treatment Market 2020 Top Manufacturers, Industry Share, Size, Trends, Growth Factor and Forecast 2025
marketwatch.com - August 31 at 9:29 AM
ACOR.OQ - Acorda Therapeutics Inc Profile | ReutersACOR.OQ - Acorda Therapeutics Inc Profile | Reuters
reuters.com - August 20 at 3:54 AM
Acorda Therapeutics: Q2 Earnings InsightsAcorda Therapeutics: Q2 Earnings Insights
finance.yahoo.com - August 5 at 1:53 AM
Acorda Therapeutics Announces Adjournment of Special Meeting of StockholdersAcorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - July 31 at 2:34 PM
Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled for August 4, 2020Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled for August 4, 2020
finance.yahoo.com - July 28 at 10:37 AM
Do Hedge Funds Love Acorda Therapeutics Inc (ACOR)?Do Hedge Funds Love Acorda Therapeutics Inc (ACOR)?
finance.yahoo.com - July 8 at 8:18 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Acorda Therapeutics, Inc. - ACORSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Acorda Therapeutics, Inc. - ACOR
finance.yahoo.com - June 16 at 7:09 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acorda Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acorda Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - June 16 at 9:06 AM
Is the Options Market Predicting a Spike in Acorda Therapeutics (ACOR) Stock?Is the Options Market Predicting a Spike in Acorda Therapeutics (ACOR) Stock?
finance.yahoo.com - June 9 at 3:29 PM
Global Non-opioid Pain Patches Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026Global Non-opioid Pain Patches Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026
www.marketwatch.com - June 7 at 9:46 AM
Acorda (ACOR) Down 11.8% Since Last Earnings Report: Can It Rebound?Acorda (ACOR) Down 11.8% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 4 at 1:05 PM
Cerebral Palsy Treatment Market Current Scenario; Who will Surpass | Allergan, Cellular Biomedicine, GlaxoSmithKlineCerebral Palsy Treatment Market Current Scenario; Who will Surpass | Allergan, Cellular Biomedicine, GlaxoSmithKline
www.marketwatch.com - June 3 at 9:44 AM
This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.